Assessing the Impact of ADC Design Philosophy Across Topoisomerase ADCs
Time: 6:00 pm
day: Conference Day One pt 2
Details:
• Breaking down the philosophy of novel ADC design and assessing validation from preclinical readouts
• Understanding the contribution of different design components towards ADC performance
• Forecasting validation of ADC philosophy impact in clinical trials
